Brevan Howard Capital Management LP Pacira Bio Sciences, Inc. Transaction History
Brevan Howard Capital Management LP
- $12.7 Billion
- Q1 2024
A detailed history of Brevan Howard Capital Management LP transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 7,395 shares of PCRX stock, worth $168,162. This represents 0.0% of its overall portfolio holdings.
Number of Shares
7,395
Previous 15,029
50.8%
Holding current value
$168,162
Previous $507,000
57.4%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
287Shares Held
48.7MCall Options Held
156KPut Options Held
623K-
Black Rock Inc. New York, NY7.91MShares$180 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$116 Million0.0% of portfolio
-
Frontier Capital Management CO LLC1.91MShares$43.5 Million0.55% of portfolio
-
State Street Corp Boston, MA1.9MShares$43.3 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.88MShares$42.8 Million0.09% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.04B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...